insights_auto
Why is EDIT down 8.87%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.67
arrow_downward
-8.87%(-0.26) 1D
$2.70
arrow_upward
+1.12% (+0.030)bedtimeAfter hours
Closed: Oct 30, 3:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.89
High
$2.92
Low
$2.60
Mkt. cap
410.06M
Avg. vol.
2.97M
Volume
2.91M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.89
High
$2.92
Low
$2.60
Mkt. cap
410.06M
Avg. vol.
2.97M
Volume
2.91M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Is the Vanguard S&P 500 ETF Still a Buy for Long-Term Investors? Here's My Honest Take.
IG Bank
·
17 minutes ago
S&P 500: Energy and Healthcare Take the Lead as Tech Slips
BigGo Finance
·
10 hours ago
Nasdaq's 5.3% October Swoon: AI Capex Fears Meet a History of 24% Rebound Years
TradingView
·
5 hours ago
Morgan Stanley's Wilson sees 9% S&P 500 drop before rally to 8,000
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc